Lazard is the leading global independent advisor to corporations, partnerships, institutions, governments, sovereign entities and individuals.

We offer a wide array of financial advisory services regarding mergers and acquisitions and other strategic matters, restructurings, capital structure, capital raising and corporate finance.


The qualities that define our culture differentiate our services:

 

  • Client-based - Relationships built on the highest standards of service and integrity
  • Experienced - Senior-most people actively engaged in client service and transactions
  • Multinational - Strong local expertise in major business centers, networked globally
  • Independent - Objective advice, free from structural conflicts of interest
  • Thoughtful - Ideas and guidance built around each client's unique situation and needs
  • Innovative - Creative solutions to our client's most complex challenges

Transactions

  • Lazard Transactions Lazard Transactions Lazard Transactions Lazard Transactions GlaxoSmithKline GSK announces three-part transaction with Novartis 22 Apr 2014 N/A
  • Lazard Transactions Lazard Transactions Lazard Transactions Lazard Transactions Partouche [Groupe Partouche] Restructuring of Groupe Partouche and Financière Partouche 31 Mar 2014 $470 Million
  • Lazard Transactions Lazard Transactions Lazard Transactions Lazard Transactions U.S. Department of Treasury Initial public offering of Ally Financial common stock 10 Apr 2014 $2,375 Million
  • Lazard Transactions Lazard Transactions Lazard Transactions Lazard Transactions Revive Pharmaceuticals Concordia Healthcare Announces Agreement to Acquire Donnatal® 20 Mar 2014 $265 Million
  • Lazard Transactions Lazard Transactions Lazard Transactions Lazard Transactions CVC Capital Partners Ltd Materis enters into exclusive negotiations with CVC with a view to selling Parex... 27 Mar 2014 $1,213 Million

Close

#= DisplayTitle # #= DisplayDescription # #= DisplayDate # #= DisplayAmount #